Tonya Rezmer
Psychiatric/Mental Health · Ocala, FLNPI 1124504121
Payments from drug & device makers
Across 139 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$234
- Alkermes, Inc.$225
- Supernus Pharmaceuticals, Inc.$167
- Teva Pharmaceuticals USA, Inc.$147
- Neurocrine Biosciences, Inc.$135
- plus $474 from 9 others
What the payments were for
- Food & beverage$2,64298%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,307 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $234 |
| Alkermes, Inc. | 7 | $225 |
| Supernus Pharmaceuticals, Inc. | 21 | $167 |
| Teva Pharmaceuticals USA, Inc. | 2 | $147 |
| Neurocrine Biosciences, Inc. | 6 | $135 |
| Corium, LLC | 13 | $116 |
| Lundbeck LLC | 5 | $92 |
| E.r. Squibb & Sons, L.L.C. | 3 | $76 |
| Indivior Inc. | 2 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$401
- UZEDY$128
- ARISTADA INITIO$100
How this compares
$2,689 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 47 | $70,404 |
| RexultiBrexpiprazole | 25 | $36,877 |
| SublocadeBuprenorphine | 11 | $22,137 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 98 | $17,055 |
| Vilazodone Hcl | 38 | $5,116 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 13 | $3,845 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $2,058 |
| Oxcarbazepine | 21 | $2,044 |
| Doxepin Hcl | 71 | $1,893 |
| Quetiapine Fumarate | 130 | $1,768 |
| Duloxetine Hcl | 94 | $1,679 |
| Clomipramine Hcl | 11 | $1,235 |
| Hydroxyzine Hcl | 30 | $1,197 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $1,092 |
| Risperidone | 109 | $1,087 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,307 | $70,40447 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $35 | $36,87725 claims |
| Indivior Inc.Sublocade | $56 | $22,13711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Ocala
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.